The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 16, 2020

Filed:

Aug. 18, 2016
Applicants:

Jinan University, Guangdong, CN;

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Pudong Shanghai, CN;

Inventors:

Ke Ding, Guangdong, CN;

Meiyu Geng, Guangdong, CN;

Li Tan, Guangdong, CN;

Jian Ding, Guangdong, CN;

Zhang Zhang, Guangdong, CN;

Jing Ai, Guangdong, CN;

Xiaomei Ren, Guangdong, CN;

Donglin Gao, Guangdong, CN;

Zhengchao Tu, Guangdong, CN;

Xiaoyun Lu, Guangdong, CN;

Dongmei Zhang, Guangdong, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4709 (2006.01); C07D 215/233 (2006.01); C07D 401/12 (2006.01); C07D 471/04 (2006.01); C07D 471/06 (2006.01); C07D 487/04 (2006.01); C07D 491/048 (2006.01); C07D 498/06 (2006.01); C07D 513/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/4709 (2013.01); C07D 215/233 (2013.01); C07D 471/04 (2013.01); C07D 471/06 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); C07D 498/06 (2013.01); C07D 513/04 (2013.01); C07D 519/00 (2013.01);
Abstract

Provided are a substituted quinolone derivative as shown by formula (I), or a pharmaceutically acceptable salt and a prodrug molecule thereof, and a pharmaceutical composition thereof, as well as the use of same in preparing drugs for the prevention and treatment of a tumor. The quinolone derivative, salt, prodrug molecule, and pharmaceutical composition thereof can be used as a protein kinase inhibitor, which is effective in inhibiting the activity of AXL protein kinase, and is capable of inhibiting the proliferation, migration and invasion of various tumor cells; and can be used in the preparation of anti-tumor drugs, especially drugs for treating hyperproliferative diseases such as a tumor in human beings and other mammals.


Find Patent Forward Citations

Loading…